Top-News
Pharmazeutika USA

TFF Pharmaceuticals Inc Aktie

Aktie
WKN:  A3E2FW ISIN:  US87241J2033 US-Symbol:  TFFP
0,0688 €
+0,0070 €
+11,23%
0,0723 $ 12.12.24
Handeln Depot/Watchlist
Aktienanzahl *
3,47 Mio.
Marktkapitalisierung *
996,29 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 08.11.2024

TFF Pharmaceuticals Inc News

14.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFP PR Newswire
09.03.21 - PR Newswire
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration Feasibility work underway to determine the compatibility of NeuroRx's ZYESAMI™ (aviptadil, ...
09.03.21 - PR Newswire
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
Feasibility Arrangement for shelf-​stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals -- ...
09.03.21 - PR Newswire
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals
Feasibility Arrangement for shelf-​stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF Pharmaceuticals PR Newswire
30.09.20 - PR Newswire
IRISYS LLC Signs a Third Contract with TFF Pharma to Produce Medication to Treat Lung Conditions, Including COVID-19
IRISYS LLC Signs a Third Contract with TFF Pharma to Produce Medication to Treat Lung Conditions, Including COVID-19 PR Newswire

Newssuche

Videos

newspaper
13.12.24
TRADING Insights Webinar vom 12.12.24
Themen: Aktienmarkt-​Entwicklung, Soft-​Commodities, wie Baumwolle, Kakao, Orangensaft, aber auch die ... Mehr »